Clinical Trial Update: Levofloxacin and Bismuth-containing Therapy Versus Quadruple Therapy as Second-line Treatment of Resistant Helicobacter Pylori Infection [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial comparing levofloxacin plus a bismuth-containing regimen versus quadruple therapy as second-line treatment for resistant Helicobacter…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Bismuth subsalicylate (bismuth subsalicylate)
• Levofloxacin (Levofloxacin)
• METRONIDAZOLE (Metronidazole)
• Omeprazole (Omeprazole)
• tetracycline (tetracycline)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Cure Rate of Helicobacter Pylori Infection | Phase 4 | Status: COMPLETED